Kamal Therapeutics, Inc., 2025-11-24
An SEC Form D private-offering notice from Hingham, MA, a $17,307,138 filer-stated offering target in Biotech. Filed 2025-11-24. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Developing an intravenous recombinant human decorin therapy to treat dystrophic epidermolysis bullosa, a rare genetic skin blistering disorder.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Somite Therapeutics, Inc., 2025-11-26, $47.5M, Boston, MA
- Neela Therapeutics, Inc., 2025-11-24, $21.5M, Lunenburg, MA
- Akeyna Inc., 2025-11-25, $1.5M, Arlington, MA
- Pelage Pharmaceuticals, Inc., 2025-11-24, $120M, Los Angeles, CA
- Atreon Orthopedics LLC, 2025-11-24, Dublin, OH
- anyvoice Inc., 2025-11-24, $50M, Boston, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.